methylphenidate 30 MG/9HR Transdermal System

RxCUI: 753441
RxNorm name: methylphenidate 30 MG/9HR Transdermal System
Display name: methylphenidate 30 MG/9HR Transdermal System
Full name: methylphenidate 30 MG/9HR Transdermal System
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:51

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Methylphenidate	METHYLPHENIDATE	Mylan Pharmaceuticals Inc.	1643b6a5-80da-4d4f-8c5f-feb907875702	2025-10-07	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 753441
Methylphenidate Transdermal System	METHYLPHENIDATE	PADAGIS US LLC	7bcff873-1fc2-45bc-a8e4-5db4edeb9bfb	2025-09-25	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 753441
Daytrana	METHYLPHENIDATE	Noven Therapeutics, LLC	2c312c31-3198-4775-91ab-294e0b4b9e7f	2025-09-01	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 753441

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
2c312c31-3198-4775-91ab-294e0b4b9e7f	methylphenidate 30 MG/9HR Transdermal System [PSN] · 9 HR methylphenidate 3.33 MG/HR Transdermal System [SCD] · methylphenidate 30 MG per 9HR Transdermal Patch [SY] · methylphenidate 30 MG/9HR Transdermal System [SY]	4	29	These highlights do not include all the information needed to use DAYTRANA ® safely and effectively. See full prescribing information for DAYTRANA. DAYTRANA ® (methylphenidate transdermal system), CII Initial U.S. Approval: 2006	20250901
7bcff873-1fc2-45bc-a8e4-5db4edeb9bfb	methylphenidate 30 MG/9HR Transdermal System [PSN] · 9 HR methylphenidate 3.33 MG/HR Transdermal System [SCD] · methylphenidate 30 MG per 9HR Transdermal Patch [SY] · methylphenidate 30 MG/9HR Transdermal System [SY]	4	7	These highlights do not include all the information needed to use METHYLPHENIDATE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for METHYLPHENIDATE TRANSDERMAL SYSTEM. Methylphenidate Transdermal System, CII Initial U.S. Approval: 2006	20250925
1643b6a5-80da-4d4f-8c5f-feb907875702	methylphenidate 30 MG/9HR Transdermal System [PSN] · 9 HR methylphenidate 3.33 MG/HR Transdermal System [SCD] · methylphenidate 30 MG per 9HR Transdermal Patch [SY] · methylphenidate 30 MG/9HR Transdermal System [SY]	4	6	These highlights do not include all the information needed to use METHYLPHENIDATE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for METHYLPHENIDATE TRANSDERMAL SYSTEM. METHYLPHENIDATE transdermal system Initial U.S. Approval: 2006	20251007